Your browser is no longer supported. Please, upgrade your browser.
Settings
BGNE BeiGene, Ltd. daily Stock Chart
BGNE [NASD]
BeiGene, Ltd.
Index- P/E- EPS (ttm)-3.56 Insider Own0.90% Shs Outstand39.30M Perf Week-4.43%
Market Cap1.42B Forward P/E- EPS next Y-3.87 Insider Trans389.44% Shs Float12.78M Perf Month-4.86%
Income-119.20M PEG- EPS next Q-0.92 Inst Own43.30% Short Float9.20% Perf Quarter20.66%
Sales1.10M P/S1293.68 EPS this Y-111.90% Inst Trans60.93% Short Ratio12.36 Perf Half Y22.75%
Book/sh9.89 P/B3.66 EPS next Y0.00% ROA-41.20% Target Price43.25 Perf Year30.86%
Cash/sh9.37 P/C3.86 EPS next 5Y- ROE-47.50% 52W Range24.53 - 41.89 Perf YTD19.27%
Dividend- P/FCF- EPS past 5Y- ROI-31.60% 52W High-13.56% Beta-
Dividend %- Quick Ratio10.70 Sales past 5Y- Gross Margin- 52W Low47.62% ATR1.35
Employees321 Current Ratio10.70 Sales Q/Q- Oper. Margin- RSI (14)36.90 Volatility3.32% 3.49%
OptionableNo Debt/Eq0.05 EPS Q/Q-21.80% Profit Margin- Rel Volume1.74 Prev Close36.32
ShortableYes LT Debt/Eq0.05 EarningsMar 27 AMC Payout- Avg Volume95.12K Price36.21
Recom1.80 SMA20-7.31% SMA50-2.77% SMA20013.13% Volume161,500 Change-0.30%
Sep-22-16Initiated Maxim Group Buy $41
Feb-29-16Initiated Robert W. Baird Outperform $44
Feb-29-16Initiated Morgan Stanley Overweight
Feb-29-16Initiated Goldman Buy $33
Mar-28-17 01:04PM  BEIGENE, LTD. Financials
Mar-24-17 10:16AM  BeiGene Ltd. :BGNE-US: Earnings Analysis: 2016 By the Numbers : March 24, 2017
Mar-22-17 04:32PM  BEIGENE, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  BeiGene Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Mar-09-17 04:22PM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:15PM  BeiGene Announces Initiation of Pivotal Study in China with BTK Inhibitor BGB-3111 in Patients with Relapsed or Refractory CLL/SLL GlobeNewswire
Mar-07-17 07:21AM  BEIGENE, LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati
07:00AM  BeiGene and Guangzhou Development District Establish Joint Venture to Build Biologics Manufacturing Facility GlobeNewswire
Mar-02-17 09:00AM  BeiGene Announces Presentation of Phase IB Data on BGB-283 at the 2017 American Association for Cancer Research Annual Meeting GlobeNewswire
09:00AM  BeiGene Announces Initiation of First Pivotal Study in China with BTK Inhibitor BGB-3111 GlobeNewswire
Feb-27-17 04:15PM  BeiGene to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-08-17 04:15PM  BeiGene to Participate in the LEERINK Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-26-17 11:11AM  Beigene Ltd (ADR) (BGNE): Heres Our Take at Insider Monkey
Jan-25-17 10:07AM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +8.24%
08:00AM  BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenströms Macroglobulinemia GlobeNewswire
Dec-30-16 09:00AM  BeiGene Announces First Patient Dosing in China Phase I Trial with Investigational Anti-PD-1 Monoclonal Antibody BGB-A317 GlobeNewswire
Dec-21-16 04:15PM  BeiGene Announces First Patient Dosing in China with Investigational PARP Inhibitor BGB-290 GlobeNewswire
Dec-16-16 07:53AM  Do Hedge Funds Love Nobilis Health Corp (USA) (HLTH)? at Insider Monkey
Dec-14-16 07:16AM  Should You Add Hawaiian Telcom HoldCo Inc (HCOM) to Your Portfolio? at Insider Monkey
06:12AM  Is Federated National Holding Co (FNHC) A Good Stock To Buy? at Insider Monkey
Dec-12-16 09:09AM  BeiGene (BGNE): Strong Industry, Solid Earnings Estimate Revisions +5.18%
Dec-09-16 01:06PM  Should You Buy Beigene Ltd (ADR) (BGNE)? at Insider Monkey
Dec-07-16 07:54AM  Cancer Genetics, Inc. Is Selected by BeiGene, Ltd. to Collaborate on Clinical Trial Services & Advance Portfolio of Novel Oncology Therapeutics GlobeNewswire
Dec-06-16 06:04AM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-05-16 10:00PM  BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenströms Macroglobulinemia at the 2016 American Society of Hematology Annual Meeting GlobeNewswire -8.26%
11:15AM  BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia at the 2016 American Society of Hematology Annual Meeting GlobeNewswire
Dec-01-16 06:11AM  [$$] Three Biotechs With Bullish Insider Buying at Barrons.com
Nov-23-16 04:25PM  BeiGene Announces Closing of $200 Million Public Offering GlobeNewswire
02:15PM  5 Stocks Insiders Love Right Now
Nov-17-16 07:27PM  BeiGene Announces Pricing of $200 Million Public Offering GlobeNewswire -11.38%
10:40AM  BeiGene Prices Secondary Offering
06:26AM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-16-16 05:59PM  BeiGene Announces Proposed Public Offering GlobeNewswire
Nov-14-16 06:17AM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +8.85%
Nov-11-16 07:00AM  BeiGene Presents Updated Clinical Data on PD-1 Antibody BGB-A317 in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 31st Annual Meeting GlobeNewswire -10.36%
06:26AM  BeiGene reports 3Q loss
Nov-10-16 11:15AM  Beigene Files for Secondary Offering +6.27%
08:59AM  BEIGENE, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:50AM  BeiGene Reports Third Quarter 2016 Financial Results GlobeNewswire
Nov-03-16 09:00AM  BeiGene Announces Oral Presentations on BTK Inhibitor BGB-3111 at the 2016 American Society of Hematology Annual Meeting GlobeNewswire -5.38%
Nov-01-16 04:15PM  BeiGene to Participate in 25th Annual Credit Suisse Healthcare Conference GlobeNewswire
Oct-10-16 10:11AM  Worst Performing Biotech IPOs of 2016 at Investopedia
Oct-07-16 05:30PM  AbbVie and JNJ, BeiGene Presents First Clinical Data for New Cancer Treatment
11:00AM  BeiGene Ltd Conference Call on BGB-3111 Data Presentation at IWWM-9 scheduled for 11:00 am ET today
09:52AM  BEIGENE, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
09:45AM  BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenstroms Macroglobulinemia at 9th International Workshop on Waldenstroms Macroglobulinemia GlobeNewswire
Oct-06-16 06:08AM  Procter & Gamble and 6 Other Stocks Spiking on Big Volume
Oct-04-16 04:15PM  BeiGene to Host Conference Call on BGB-3111 Data Presentation at IWWM-9 GlobeNewswire
Oct-03-16 04:15PM  BeiGene Appoints Ross Pettit as Senior Vice President, Global Development Operations GlobeNewswire
Sep-22-16 05:45AM  Coverage initiated on BeiGene by Maxim Group
Sep-15-16 08:25AM  BeiGene (BGNE) Catches Eye: Stock Adds 6% in Session
Sep-11-16 07:00PM  BeiGene Receives Approval to Initiate Clinical Trials in China with PD-1 Antibody BGB-A317 GlobeNewswire
Sep-06-16 04:15PM  BeiGene Appoints Jane Huang, M.D. as Chief Medical Officer, Hematology GlobeNewswire
Sep-02-16 02:26PM  These 5 Stocks Are Poised for Big Breakouts
Aug-31-16 04:15PM  BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences GlobeNewswire
Aug-24-16 04:15PM  BeiGene Appoints Amy Peterson, M.D. as Chief Medical Officer, Immuno-oncology GlobeNewswire
Aug-18-16 08:00AM  BeiGene Receives Approval to Initiate Clinical Trials in China with PARP Inhibitor BGB-290 GlobeNewswire
Aug-10-16 04:34PM  BEIGENE, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  BeiGene Reports Second Quarter 2016 Financial Results GlobeNewswire
Jul-05-16 04:30PM  BeiGene Announces First Patient Dosing for Investigational BTK Inhibitor BGB-3111 in China GlobeNewswire
Jun-29-16 04:36PM  BeiGene Announces Initiation of a Combination Trial of the BTK Inhibitor BGB-3111 with the PD-1 Antibody BGB-A317 GlobeNewswire
Jun-14-16 04:44PM  U.S. regulator says too many drugmakers chasing same cancer strategy
Jun-10-16 07:00AM  U.S. regulator says too many drugmakers chasing same cancer strategy
Jun-06-16 08:07AM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  BeiGene to Participate in Goldman Sachs 37th Annual Global Healthcare Conference GlobeNewswire
Jun-05-16 09:00AM  BeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-26-16 09:34AM  Hedge Funds Favorite Recently-Public Companies amid Atrophied IPO Market at Insider Monkey
May-24-16 10:53AM  Biotech-Focused VHCP Managements Bullish Moves and New Picks at Insider Monkey
May-19-16 06:00AM  BeiGene Announces Presentation on BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-12-16 04:25PM  BEIGENE, LTD. Files SEC form 10-Q, Quarterly Report
May-11-16 04:23PM  BEIGENE, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  BeiGene Reports First Quarter 2016 Financial Results GlobeNewswire
May-04-16 05:40PM  BEIGENE, LTD. Files SEC form 8-K, Change in Directors or Principal Officers
05:25PM  BeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development GlobeNewswire
Apr-21-16 09:30AM  Opening Bell, April 21, 2016
Apr-20-16 10:00AM  BeiGene (Nasdaq: BGNE) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Apr-19-16 09:26AM  BeiGene Ltd. :BGNE-US: Earnings Analysis: 2015 By the Numbers
Apr-18-16 07:40AM  BEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Apr-17-16 05:15PM  BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting GlobeNewswire
Apr-11-16 05:10PM  BEIGENE, LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati
05:00PM  BeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer GlobeNewswire
Mar-30-16 04:24PM  BEIGENE, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BeiGene Reports Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire
Mar-29-16 04:17PM  BEIGENE, LTD. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-16-16 05:48PM  BeiGene Announces Presentations on BGB-283 and Other Pipeline Agents at the 2016 American Association for Cancer Research Annual Meeting GlobeNewswire
Mar-09-16 04:39PM  The Hottest IPO of 2016 Is Crashing at Fortune
Mar-07-16 08:00AM  BeiGene Receives Approval to Initiate Clinical Trials in China With BGB-3111 GlobeNewswire -7.97%
Mar-01-16 08:00AM  BeiGene to Present at Cowen and Company 36th Annual Health Care Conference GlobeNewswire
Feb-29-16 02:25PM  Street Talk: CLR, HLT, BGNE, NFX & FET
Feb-22-16 04:04PM  13D Filing: Baker Bros. Advisors and Beigene, Ltd. (BGNE) at Insider Monkey
12:03PM  13D Filing: Billionaire Lei Zhangs Hillhouse Capital Management Reports Stake in Beigene, Ltd. (BGNE) at Insider Monkey
Feb-12-16 12:32PM  Volatile Market Flatlines Biotech IPOs
08:04AM  No Relief in Sight for IPO Market --Morning MoneyBeat at The Wall Street Journal
Feb-11-16 05:25PM  BEIGENE, LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, -10.34%
04:01PM  Only biotech companies have braved IPO market this year with insider help at MarketWatch
Feb-10-16 12:39PM  Bill Gates Cascade Investment Boosts AutoNation Inc. (AN) Stake, Buffett Keeps Buying Phillips 66 (PSX), Plus Baker Bros. Latest Move at Insider Monkey
Feb-09-16 11:04AM  Little Hope For IPO Recovery In First Quarter at Forbes -12.25%
Feb-08-16 04:30PM  BeiGene Announces Closing of Its Initial Public Offering GlobeNewswire -7.05%
Feb-07-16 09:10AM  Up to 8 IPOs Could Launch in the Coming Week at 24/7 Wall St.
Feb-03-16 05:23PM  First IPOs of 2016 BeiGene, Editas Medicine Surge On First Day
Chinese biotech developing cancer therapies for China and global markets.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wang XiaodongDirectorMar 24Sale36.6018,787687,63486,650Mar 24 06:57 PM
Wang XiaodongDirectorMar 23Sale37.0011,041408,462105,437Mar 24 06:57 PM
Wang XiaodongDirectorMar 22Sale37.758,279312,517116,478Mar 24 06:57 PM
OYLER JOHNChief Executive OfficerMar 20Sale40.0213,234529,611181,489Mar 20 07:06 PM
OYLER JOHNChief Executive OfficerMar 17Sale40.022,717108,737194,723Mar 20 07:06 PM
OYLER JOHNChief Executive OfficerMar 16Sale38.7716,038621,725197,440Mar 20 07:06 PM
Wang XiaodongDirectorMar 10Sale39.947,304291,702124,757Mar 10 07:16 PM
Wang XiaodongDirectorMar 09Sale39.9518,596742,843132,061Mar 10 07:16 PM
Wang XiaodongDirectorMar 08Sale39.7810,992437,211150,657Mar 10 07:16 PM
OYLER JOHNChief Executive OfficerMar 06Sale40.2319,816797,258213,478Mar 06 07:00 PM
OYLER JOHNChief Executive OfficerMar 03Sale40.8340,0911,636,968233,294Mar 06 07:00 PM
OYLER JOHNChief Executive OfficerMar 02Sale41.2549,0922,025,104273,385Mar 06 07:00 PM
Wang XiaodongDirectorFeb 27Sale38.104,444169,328161,649Feb 27 09:11 PM
Wang XiaodongDirectorFeb 24Sale38.1428,4021,083,114166,093Feb 27 09:11 PM
Wang XiaodongDirectorFeb 23Sale38.575,505212,351194,495Feb 27 09:11 PM
OYLER JOHNChief Executive OfficerFeb 21Sale39.9810,359414,162322,477Feb 21 07:23 PM
OYLER JOHNChief Executive OfficerFeb 17Sale40.677,204292,981332,836Feb 21 07:23 PM
OYLER JOHNChief Executive OfficerFeb 16Sale40.6547,4001,926,867340,040Feb 21 07:23 PM
Malley ThomasDirectorNov 23Buy32.0030,000960,00030,000Nov 28 04:02 PM
Wang XiaodongDirectorNov 23Sale32.0093,7503,000,0000Nov 28 04:04 PM
BAKER BROS. ADVISORS LPDirectorNov 18Buy32.001,760,49556,335,8403,317,977Nov 21 06:13 PM